SUMMARY The Seralyzer chemistries for total bilirubin, cholesterol, and creatinine have been examined in the routine hospital laboratory, and have demonstrated good correlation and precision when compared to established routine methodologies. The system has proved to be reliable and easy to use.
Reflectance spectroscopy is being used increasingly in the field of clinical chemistry for the measurement of various analytes in blood. Its use in conjunction with solid-phase reagents makes the system versatile, and extends its applications to areas beyond that of clinical chemistry laboratories, who are dependent on the conventional wet chemistry techniques. This is available as the SeralyzerTm system (Ames Division, Miles Laboratories Limited). The system can provide a "Stat" function for the provision of urgent results, often extending the repertoire of tests available in this way.
Studies have already shown the suitability of the system for the routine measurement of glucose, urea and uric acid' 2 and a preliminary study on the measurement of bilirubin has also been made. 3 Recently, Seralyzer methods have been developed for the measurement of total bilirubin, cholesterol, and creatinine, in serum. These have been studied to assess the performance in routine clinical use in the hospital laboratory, and were found to be convenient and reliable for routine clinical analysis.
Material and methods

THE SERALYZER SYSTEM
The Seralyzer system basically comprises a microprocessor-controlled reflectance photometer in association with dedicated solid-phase reagent strips, as briefly outlined previously.2 The principles of the system are described by Zipp.4 Modules are supplied for each test parameter. Within-run Seralyzer precision using a normal plasma pool can be seen from Table 3 ; between-and overall control sera precision data are presented in Table 4 Creatinine precision results-obtained by the assay of triplicates ofthree control sera with each batch of patient samples Two of these chemistries do not require sample dilution, therefore enhancing simplicity and rapidity of estimation. Although the cholesterol system requires sample dilution, the pipetter/diluter supplied with the system simplifies this procedure.
In keeping with good analytical practice, quality control samples should be run with each batch of analyses. Assigned values for the Seralyzer chemistries are now incorporated in the package inserts for many of the commercial quality control materials.
Very encouraging results have been produced from these studies. There is, therefore, every reason to believe that for the trained operator, the Seralyzer system can be used with confidence as a "Stat" analyser in hospital laboratories, the private sector, or established General Practitioner centres.
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